QurAlis Email Format
Biotechnology ResearchMassachusetts, United States51-200 Employees
QurAlis is a biotechnology research company headquartered in Cambridge, Massachusetts, focused on neurodegenerative and neurological diseases and on developing precision medicines. The company aims to translate scientific breakthroughs into disease-modifying therapies, pursuing a pipeline that includes ALS and other severe conditions defined by genetics and clinical biomarkers. The organization has 51 to 200 employees. Reported revenue is in the range of $25 million to $50 million, and total funding is about $88 million. In January 2024, QurAlis opened EU headquarters in the Netherlands, reflecting its international expansion.